Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors.

Skrahina A, Hurevich H, Zalutskaya A, Sahalchyk E, Astrauko A, Hoffner S, Rusovich V, Dadu A, de Colombani P, Dara M, van Gemert W, Zignol M.

Bull World Health Organ. 2013 Jan 1;91(1):36-45. doi: 10.2471/BLT.12.104588. Epub 2012 Nov 26.

2.

Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk.

Skrahina A, Hurevich H, Zalutskaya A, Sahalchyk E, Astrauko A, van Gemert W, Hoffner S, Rusovich V, Zignol M.

Eur Respir J. 2012 Jun;39(6):1425-31. doi: 10.1183/09031936.00145411. Epub 2011 Oct 17.

3.

Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011.

Ulmasova DJ, Uzakova G, Tillyashayhov MN, Turaev L, van Gemert W, Hoffmann H, Zignol M, Kremer K, Gombogaram T, Gadoev J, du Cros P, Muslimova N, Jalolov A, Dadu A, de Colombani P, Telnov O, Slizkiy A, Kholikulov B, Dara M, Falzon D.

Euro Surveill. 2013 Oct 17;18(42). pii: 20609.

4.

Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.

Sethi S, Mewara A, Dhatwalia SK, Singh H, Yadav R, Singh K, Gupta D, Wanchu A, Sharma M.

BMC Infect Dis. 2013 Mar 15;13:137. doi: 10.1186/1471-2334-13-137.

5.

Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in Belarus.

Wollenberg KR, Desjardins CA, Zalutskaya A, Slodovnikova V, Oler AJ, QuiƱones M, Abeel T, Chapman SB, Tartakovsky M, Gabrielian A, Hoffner S, Skrahin A, Birren BW, Rosenthal A, Skrahina A, Earl AM.

J Clin Microbiol. 2017 Feb;55(2):457-469. doi: 10.1128/JCM.02116-16. Epub 2016 Nov 30.

6.

Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.

Liu Z, Shilkret KL, Finelli L.

Int J Epidemiol. 1998 Feb;27(1):121-6.

PMID:
9563705
7.

Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia.

Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G.

Int J Infect Dis. 2015 Oct;39:57-61. doi: 10.1016/j.ijid.2015.08.013. Epub 2015 Sep 12.

8.

Rates and risk factors for drug resistance tuberculosis in Northeastern China.

Liu Q, Zhu L, Shao Y, Song H, Li G, Zhou Y, Shi J, Zhong C, Chen C, Lu W.

BMC Public Health. 2013 Dec 13;13:1171. doi: 10.1186/1471-2458-13-1171.

9.

Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.

van Altena R, de Vries G, Haar CH, de Lange WC, Magis-Escurra C, van den Hof S, van Soolingen D, Boeree MJ, van der Werf TS.

Int J Tuberc Lung Dis. 2015 Apr;19(4):406-12. doi: 10.5588/ijtld.14.0838.

PMID:
25859995
10.

Primary drug-resistant tuberculosis in Hanoi, Viet Nam: present status and risk factors.

Hang NT, Maeda S, Lien LT, Thuong PH, Hung NV, Thuy TB, Nanri A, Mizoue T, Hoang NP, Cuong VC, Ngoc KT, Sakurada S, Endo H, Keicho N.

PLoS One. 2013 Aug 13;8(8):e71867. doi: 10.1371/journal.pone.0071867. eCollection 2013.

11.

Nationwide survey of drug-resistant tuberculosis in the United States.

Bloch AB, Cauthen GM, Onorato IM, Dansbury KG, Kelly GD, Driver CR, Snider DE Jr.

JAMA. 1994 Mar 2;271(9):665-71.

PMID:
8080502
12.

Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.

van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Bekembayeva G, Ismailov S.

Int J Tuberc Lung Dis. 2013 Apr;17(4):526-31. doi: 10.5588/ijtld.12.0703.

PMID:
23485387
13.

Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.

Wang K, Chen S, Wang X, Zhong J, Wang X, Huai P, Wu L, Wang L, Jiang S, Li J, Peng Y, Yao H, Ma W.

Microb Drug Resist. 2014 Aug;20(4):294-300. doi: 10.1089/mdr.2013.0145. Epub 2013 Dec 13.

PMID:
24328894
14.
15.

Risk factors for multidrug resistant tuberculosis in Europe: a systematic review.

Faustini A, Hall AJ, Perucci CA.

Thorax. 2006 Feb;61(2):158-63. Epub 2005 Oct 27. Review.

16.

Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, China.

Qi YC, Ma MJ, Li DJ, Chen MJ, Lu QB, Li XJ, Li JL, Liu W, Cao WC.

PLoS One. 2012;7(2):e32103. doi: 10.1371/journal.pone.0032103. Epub 2012 Feb 22.

17.

Drug-resistant tuberculosis in South African gold miners: incidence and associated factors.

Churchyard GJ, Corbett EL, Kleinschmidt I, Mulder D, De Cock KM.

Int J Tuberc Lung Dis. 2000 May;4(5):433-40.

PMID:
10815737
18.

Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010.

Zignol M, van Gemert W, Falzon D, Sismanidis C, Glaziou P, Floyd K, Raviglione M.

Bull World Health Organ. 2012 Feb 1;90(2):111-119D. doi: 10.2471/BLT.11.092585. Epub 2011 Nov 7.

19.

Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.

Al-Hajoj S, Varghese B, Shoukri MM, Al-Omari R, Al-Herbwai M, Alrabiah F, Alrajhi AA, Abuljadayel N, Al-Thawadi S, Zumla A, Zignol M, Raviglione MC, Memish Z.

Antimicrob Agents Chemother. 2013 May;57(5):2161-6. doi: 10.1128/AAC.02403-12. Epub 2013 Mar 4.

20.

Characterizing Mycobacterium tuberculosis isolates from Karachi, Pakistan: drug resistance and genotypes.

Ayaz A, Hasan Z, Jafri S, Inayat R, Mangi R, Channa AA, Malik FR, Ali A, Rafiq Y, Hasan R.

Int J Infect Dis. 2012 Apr;16(4):e303-9. doi: 10.1016/j.ijid.2011.12.015. Epub 2012 Feb 23.

Supplemental Content

Support Center